Skip to content

RLAY

Relay Therapeutics, Inc.

Stock

$18.96+0.47 (+2.54%)Close Oct 2, 2026

Operating income, 2025
−$303M

Operating income

Operating income by fiscal year

PeriodOperating incomeYoY
2025−$303M—
2024−$372M—
2023−$373M—
2022−$299M—
2021−$365M—
2020−$56M—
2019−$84M—